A protein-based smallpox vaccine protects non-human primates from a lethal monkeypox virus challenge

Concerns about infections caused by orthopoxviruses, such as variola and monkeypox viruses, drive ongoing efforts to develop novel smallpox vaccines that are both effective and safe to use in diverse populations. A subunit smallpox vaccine comprising vaccinia virus membrane proteins A33, B5, L1, A27...

Descripción completa

Detalles Bibliográficos
Autores principales: Buchman, George W., Cohen, Matthew E., Xiao, Yuhong, Richardson-Harman, Nicola, Silvera, Peter, DeTolla, Louis J., Davis, Heather L., Eisenberg, Roselyn J., Cohen, Gary H., Isaacs, Stuart N.
Formato: Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2010
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2939220/
https://www.ncbi.nlm.nih.gov/pubmed/20659519
http://dx.doi.org/10.1016/j.vaccine.2010.07.030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2939220/
https://www.ncbi.nlm.nih.gov/pubmed/20659519
http://dx.doi.org/10.1016/j.vaccine.2010.07.030

Ejemplares similares